Trial Profile

Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 28 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aspirin (Primary) ; Atorvastatin (Primary) ; Clopidogrel (Primary) ; Omeprazole (Primary) ; Rivaroxaban (Primary)
Indications Acute coronary syndromes; Coronary artery disease; COVID 2019 infections; Diabetes mellitus; Hypertension
Focus Therapeutic Use
Acronyms C-19-ACS

Most Recent Events

11 Apr 2022 Status changed from recruiting to discontinued due to difficulty in recruiting eligible participants.
14 Apr 2020 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com